Use of plant oil-bodies in vaccine delivery systems
OwnerAnthony B Schryvers, Wendy A Hutchins +2inventors
InventorsAnthony B Schryvers, Wendy A Hutchins, Maurice M Moloney, Joenel Alcantra
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of oil bodies as a vaccine adjuvant and delivery system for administration of vaccines by parenteral, mucosal (oral, nasal, pulmonary) and transdermal routes. In addition, the present invention relates to methods of eliciting an immune response in an animal by administering oil body-antigen complexes to said mammal. Finally, the present invention relates to methods of preparing oil body-antigen complexes.
Claims54
A method of eliciting an immune response in an animal, wherein said method comprises administering a formulation comprising an oil body and an antigen to said animal.
A method of eliciting an immune response in an animal, wherein said method comprises administering an oil body-antigen complex produced by a method comprising the steps of:
- a) introducing into a cell a chimeric nucleic acid sequence comprising:
- 1) a first nucleic acid sequence capable of regulating transcription in said cell operatively linked to;
- 2) a second nucleic acid sequence encoding a recombinant fusion polypeptide comprising (i) a first nucleic acid sequence encoding a sufficient portion of an oil body protein to provide targeting to an oil body linked in reading frame to (ii) a second nucleic acid sequence encoding a linker molecule operatively linked to;
- 3) a third nucleic acid sequence capable of terminating transcription in said cell;
- b) growing said cell under conditions to permit expression of said fusion polypeptide in a progeny cell comprising oil bodies;
- c) isolating said oil bodies comprising the linker molecule;
- d) linking an antigen to said oil body via said linker molecule to form an oil body-antigen complex;
- and
- e) administering the said oil body-antigen complex to said animal.
A method of eliciting an immune response in an animal, wherein said method comprises administering an oil body-antigen complex produced by a method comprising the steps of:
- a) introducing into a cell a chimeric nudeic acid sequence comprising:
- 1) a first nudeic acid sequence capable of regulating transcription in said cell operatively linked to;
- 2) a second nudeic acid sequence encoding a recombinant fusion polypeptide comprising (i) a first nudeic acid sequence encoding a sufficient portion of an oil body protein to provide targeting to an oil body linked in reading frame to (ii) a second nudeic acid sequence encoding an antigen operatively linked to;
- 3) a third nucleic add sequence capable of terminating transcription in said cell;
- b) growing said cell under conditions to permit expression of said antigen in a progeny cell resulting in the formation of an oil body-antigen complex;
- c) isolating said oil body-antigen complex;
- and
- d) administering the said plant oil body-antigen complex to said animal.
A method of preparing an oil body-antigen complex comprising the steps of:
- a) isolating an oil body;
- and
- b) linking an antigen to said oil body to form a oil body-antigen complex.
A method of preparing an oil-body-antigen complex comprising the steps of:
- a) introducing into a cell a chimeric nucleic acid sequence comprising:
- 1) a first nucleic acid sequence capable of regulating transcription in said cell operatively linked to;
- 2) a second nucleic acid sequence encoding a recombinant fusion polypeptide comprising (i) a first nucleic acid sequence encoding a sufficient portion of an oil body protein to provide targeting to an oil body linked in reading frame to (ii) a second nucleic acid sequence encoding a linker molecule operatively linked to;
- 3) a third nucleic acid sequence capable of terminating transcription in said cell;
- b) growing said cell under conditions to permit expression of said fusion polypeptide in a progeny cell comprising oil bodies;
- c) isolating said oil bodies comprising the linker molecule;
- and
- d) linking an antigen to said oil body via said linker molecule to form an oil body-antigen complex.
A method of preparing an oil body-antigen complex comprising the steps of:
- a) introducing into a cell a chimeric nucleic add sequence comprising:
- 1) a first nucleic acid sequence capable of regulating transcription in said cell operatively linked to;
- 2) a second nucleic add sequence encoding a recombinant fusion polypeptide comprising (i) a first nucleic acid sequence encoding a sufficient portion of an oil body protein to provide targeting to an oil body linked in reading frame to (ii) a second nucleic acid sequence encoding an antigen operatively linked to;
- 3) a third nucleic acid sequence capable of terminating transcription in said cell;
- b) growing said cell under conditions to permit expression of said antigen in a progeny cell resulting in the formation of an oil body-antigen complex;
- and
- c) isolating said oil body-antigen complex.
A vaccine formulation comprising an oil body-antigen complex.
A vaccine formulation comprising of a oil body-antigen complex and an immunostimulatory molecule.
Use of a vaccine formulation comprising an oil body-antigen complex for immunizing an animal against infection by a bacterial, viral or parasitic pathogen.
Use of a vaccine formulation comprising an oil body-antigen complex for immunizing an animal against cancer cells.
Use of a vaccine formulation comprising an oil body-antigen complex for immunizing an animal in order to modulate the immune response involved in an autoimmune reaction.
Use of a vaccine formulation comprising an oil body-antigen complex for immunizing an animal in order to modulate the immune response involved in an allergic reaction.
Dependencies are inferred from the claim text.